Analyzing Finasteride Data
January 1995
in “
Neurourology and Urodynamics
”
TLDR Finasteride slightly improves prostate symptoms but has minimal difference from placebo.
This document analyzes data on the safety and efficacy of finasteride in treating benign prostatic hyperplasia. The study found that while the drug led to a reduction in prostate volume and improvement in symptom scores, the difference between the placebo and finasteride groups was almost negligible. The paper suggests the need for publishing correlation studies of both the benefits and side-effects to allow for informed physician and patient decisions.
